Recombinant Human LILRA2/CD85h/ILT1 Protein

https://www.xunlan.net/web/image/product.template/298247/image_1920?unique=62b3f9a

¥ 16,719.90 16719.9 CNY ¥ 16,719.90

¥ 0.00

Not Available For Sale

规格或纯度 ActiBioPure™, 生物活性, 无动物源, Carrier Free, ≥95%(SDS-PAGE)
货号(SKU) rp167152
品牌 阿拉丁
  • 包装

此组合不存在。

条款和条件
30天退款保证
运输:2-3 个工作日

规格


Cas Number
规格或纯度 ActiBioPure™, 生物活性, 无动物源, Carrier Free, ≥95%(SDS-PAGE)
级别 无动物源,无载体,生物活性,ActiBioPure™
纯度 ≥95%(SDS-PAGE)
包装 1mg100μg10μg50μg

产品信息


品牌 阿拉丁
Animal free Yes
Carrier free Yes
预测分子量 48 kDa
氨基酸 24-449 aa
Protein length 蛋白片段
表达系统 HEK293
生物活性 Measured by its binding ability in a functional ELISA. When Recombinant Human LILRA2/CD85h/ILT1 is coated at 2 µg/mL, Recombinant Human Angiopoietin-like Protein 7/ANGPTL7 binds with a typical ED50 of 0.2 -1.2 μg/mL.
蛋白标签 C-His
序列 GHLPKPTLWAEPGSVIIQGSPVTLRCQGSLQAEEYHLYRENKSASWVRRIQEPGKNGQFPIPSITWEHAGRYHCQYYSHNHSSEYSDPLELVVTGAYSKPTLSALPSPVVTSGGNVTLQCVSQVAFDGFILCKEGEDEHPQRLNSHSHARGWSWAIFSVGPVSPSRRWSYRCYAYDSNSPYVWSLPSDLLELLVPGVSKKPSLSVQPGPMVAPGESLTLQCVSDVGYDRFVLYKEGERDFLQRPGWQPQAGLSQANFTLGPVSPSHGGQYRCYSAHNLSSEWSAPSDPLDILITGQFYDRPSLSVQPVPTVAPGKNVTLLCQSRGQFHTFLLTKEGAGHPPLHLRSEHQAQQNQAEFRMGPVTSAHVGTYRCYSSLSSNPYLLSLPSDPLELVVSEAAETLSPSQNKTDSTTTSLGQHPQDYTVENHHHHHH
复溶(Reconstitution) Reconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
简短描述 Animal Free, ≥95% (SDS-PAGE), Active, 293F, C-His tag, 24-449 aa
英文简短描述 Animal Free, ≥95% (SDS-PAGE), Active, 293F, C-His tag, 24-449 aa
稳定性和储存 在 -20~-80℃ 下可保存 1 年以上。收货后建议分装。避免冷冻/解冻循环。
过滤标签 CD85,LILRA2,CD85h,ILT1,LIR7,Gene ID: 11027,Accession#: Q8N149
储存温度 -20°C储存,避免反复冻融
运输条件 超低温冰袋运输
Accession ID Q8N149-1
物理形态 冻干(Lyophilized)
储存缓冲液 Lyophilized from 10mM PBS, 5% Trehalose, 5% Mannitol, pH7.4.
内毒素浓度 <0.1 EU/μg
Source 重组表达
英文描述

Function
Part of the innate immune responses against microbial infection (PubMed:12529506, PubMed:27572839). Specifically recognizes a set of N-terminally truncated immunoglobulins that are produced via cleavage by proteases from a range of pathogenic bacteria and fungi, including L.pneumophila, M.hyorhinis, S.pneumoniae, S.aureus and C.albicans (PubMed:27572839). Recognizes epitopes that are in part in the variable region of the immunoglobulin light chains, but requires also the constant region for signaling (PubMed:27572839). Binds to a subset of cleaved IgM, IgG3 and IgG4 molecules, but does not bind cleaved IgA1 (PubMed:27572839). Binding of N-terminally truncated immunoglobulins mediates activation of neutrophils (PubMed:27572839). In monocytes, activation leads to the release of CSF2, CF3, IL6, CXCL8 and CCL3 and down-regulates responses to bacterial lipopolysaccharide (LPS), possibly via down-regulation of TLR4 expression and reduced signaling via TLR4 (PubMed:22479404). In eosinophils, activation by ligand binding leads to the release of RNASE2, IL4 and leukotriene C4 (PubMed:12529506). Does not bind class I MHC antigens(PubMed:19230061).

SDS-PAGE 60 - 90 kDa, under reducing conditions; 60 - 90 kDa, under non-reducing conditions.

技术规格说明书


质检证书(CoA,COO,BSE/TSE)